From a frontier school to a global leader in medical innovation
Founded seven years before Minnesota even became a state, this institution has evolved from a struggling territorial college into a massive research powerhouse. It has hosted world-first surgeries, developed the first portable pacemaker, and even engineered the Honeycrisp apple.
The University of Minnesota Twin Cities has a turbulent history of survival. Established in 1851 by the Minnesota Territorial Legislature, the university faced a complete shutdown during the American Civil War due to financial crises. It was only revived in 1867 after receiving land-grant status via the Morrill Act of 1862—a process that involved the expropriation of lands from the Dakota people. The school's long-term stability was eventually secured by the 1876 generosity of flour miller John S. Pillsbury, whose support earned him the title 'The Father of the University.'
The institution has since become a global epicenter for medical breakthroughs. In the 1950s, researchers C. Walton Lillehei and F. John Lewis achieved the first successful open-heart surgery using cross-circulation techniques. This era of innovation continued with the development of the bubble oxygenator in 1955 and the first human implant of an artificial heart valve in 1958. Even the technology used to regulate heart rhythms owes a debt to the campus, as Earl Bakken developed the first portable pacemaker here in 1958.
Today, the university is a massive, multifaceted system. The Twin Cities campus alone serves over 56,000 students as of fall 2024, making it one of the ten largest campuses in the United States. Beyond medicine, its impact reaches into agriculture and design, evidenced by the 1991 creation of the Honeycrisp apple. With $1.202 billion in research and development expenditures recorded in 2022, the university remains a primary driver of scientific and economic progress.
Source: University of Minnesota
